Congress Materials – Rheumatology Winter Clinical Symposium (RWCS 2025)

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

Achievement of Low Disease Activity/Remission in Guselkumab-Treated Patients With Moderately-Highly Active Psoriatic Arthritis Regardless of Baseline Characteristics: Pooled Post-Hoc Analysis of Two Phase 3/Randomized Studies

Philip J. Mease, Alice B. Gottlieb, Iain B. McInnes, Natalie J. Shiff, Emmanouil Rampakakis, Francois Nantel, Jenna Parrett, Frederic Lavie, Proton Rahman

 

View poster

Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-Controlled Study

Christopher T. Ritchlin, Ennio Lubrano, Maria Sole Chimenti, Evan Leibowitz, Mohamed Sharaf, Emmanouil Rampakakis, Francois Nantel, Frederic Lavie, Atul Deodhar

 

View poster

On-Label Persistence Through 24 Months in Patients with Psoriatic Arthritis Using Guselkumab or Subcutaneous Interleukin-17A Inhibitors

Philip J. Mease, Jessica Walsh, Timothy P. Fitzgerald, Soumya D. Chakravarty, Bruno Emond, Carmine Rossi, Samuel Schwartzbein, Kana Yokoji, Yuxi Wang, Patrick Lefebvre, Dominic Pilon, Linda Hou, Shikha Singla, Joseph F. Merola

 

View poster

On-Label Persistence Through 24 Months Among Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous TNF Inhibitors

Philip J Mease, Jessica Walsh, Timothy P Fitzgerald, Soumya D Chakravarty, Bruno Emond, Carmine Rossi, Samuel Schwartzbein, Kana Yokoji, Yuxi Wang, Patrick Lefebvre, Dominic Pilon, Linda Hou, Shikha Singla, Joseph F Merola

 

View poster

VISIBLE: Guselkumab Impact on Psoriatic Arthritis at Week 16 in Participants With Moderate to Severe Psoriasis Across All Skin Tones

Alice B. Gottlieb, Amy McMichael, Tina Bhutani, Olivia Choi, Theodore Alkousakis, Jenny Jeyarajah, Donna Febres, Oyediran Adelakun, Soumya D. Chakravarty, Daphne Chan, Joseph F. Merola

 

View poster